A subsequent report by Bennani-Baiti confirmed these findings and extended the high expressing LSD1 sarcoma groups to Ewing sarcoma, chondrosarcoma and osteosarcoma [69], subtypes which were not investigated by Schildhaus et al. Although LSD1 expression in Ewing sarcoma was comparable to that of rhabdomyosarcoma, the most significant LSD1-expressing sarcoma subtype, no studies have hitherto to date examined the prognostic value of LSD1 expression in Ewing sarcoma. This evidence concerns the gene KDM1A and sarcoma.